Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer

Cancer Chemotherapy and Pharmacology

Volumn 71, Issue 5, 2013, Pages 1309-1314

  Tsuburaya, Akira ^a   Nagata, Naoki ^b   Cho, Haruhiko ^a   Hirabayashi, Naoki ^c   Kobayashi, Michiya ^d   Kojima, Hiroshi ^e   Munakata, Yasuhiro ^f   Fukushima, Ryoji ^g   Kameda, Yoichi ^a   Shimoda, Tadakazu ^h   Oba, Koji ⁱ   Sakamoto, Junichi ^j  

^a KANAGAWA CANCER CENTER   (Japan)

^b Kitakyushu General Hospital   (Japan)

^c HIROSHIMA CITY ASA HOSPITAL   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f Nagano Municipal Hospital   (Japan)

^g TEIKYO UNIVERSITY   (Japan)

^h NATIONAL CANCER CENTER   (Japan)

ⁱ HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^j Tokai Central Hospital of Japan Mutual Aid Association of Public School Teachers   (Japan)

more..

Author keywords

Cisplatin; Gastric cancer; Neoadjuvant chemotherapy; Paclitaxel; Pathological response

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CONSTIPATION; DIARRHEA; DISTANT METASTASIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FAINTNESS; FATIGUE; FEMALE; GASTRECTOMY; HUMAN; INFECTION; LEUKOPENIA; LIVER METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; NULL HYPOTHESIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEUM METASTASIS; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; STOMACH CANCER; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PACLITAXEL; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84877927934     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2130-0     Document Type: Article

References (17)

1. Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP (2006) A phase II trial of neoadjuvant cisplatin- fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol 17:1404-1411
2. Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26
3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer
5. Habermann CR, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler C, Dieckmann C, Schoder V, Adam G (2004) Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 230:465-471
6. A Japanese Gastric Cancer (1998) Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1:10-24
7. Kobayashi M, Sakamoto J, Namikawa T, Okamoto K, Okabayashi T, Ichikawa K, Araki K (2006) Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients. World J Gastroenterol 12:1412-1415
8. Kurokawa Y, Sasako M, Ando N, Sano T, Igaki H, Iwasaki Y, Tsuburaya A, Fukuda H (2009) Validity of response criteria in neoadjuvant chemotherapy against gastric and esophageal cancer: Correlative analyses of multicenter JCOG trials. Gastrointestinal Cancers Symposium, Orland. p. Abst 11
9. Macdonald JS (2005) Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 90:166-170
10. Nagata N, Kimura M, Hirabayashi N, Tuburaya A, Murata T, Kondo K, Fukuda Y, Kobayashi M, Miyashita Y, Nakao A, Sakamoto J (2008) Phase II study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer. Hepatogastroenterology 55:1846-1850
11. Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Van Cutsem E, Buyse M (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303:1729-1737
12. Sakamoto J, Matsui T, Kodera Y (2009) Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer 12:69-78
13. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810-1820
14. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11:439-449
15. Tsuburaya A, Sakamoto J, Morita S, Kodera Y, Kobayashi M, Miyashita Y, Macdonald JS (2005) A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the stomach cancer adjuvant multi-institutional trial group (Samit) trial. Jpn J Clin Oncol 35:672-675
16. Yoshikawa T, Sasako M, Yamamoto S, Sano T, Imamura H, Fujitani K, Oshita H, Ito S, Kawashima Y, Fukushima N (2009) Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 96:1015-1022
17. Yoshikawa T, Tsuburaya A, Morita S, Kodera Y, Ito S, Cho H, Miyashita Y, Sakamoto J (2010) A comparison of multimodality treatment: two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized Phase II trial (COMPASS). Jpn J Clin Oncol 40:369-372